Skip to main content

Table 2 Patient characteristics at enrolment date

From: Real-world costs of autosomal dominant polycystic kidney disease in the Nordics

Patient characteristic

CKD 1–3 (n = 64)

CKD 4–5 (n = 55)

Dialysis (n = 61)

Transplant (n = 63)

P value

Country, n (%)a

    

<0.0001

 Denmark

26 (41)

32 (58)

32 (52)

28 (44)

 

 Sweden

19 (30)

12 (22)

14 (23)

13 (21)

 

 Norway

19 (30)

11 (20)

4 (7)

16 (25)

 

 Finland

0 (0)

0 (0)

11 (18)

6 (10)

 

Sex (female), n (%)

38 (59)

29 (53)

33 (54)

31 (49)

0.7144

Age (years), mean ± SDb

52 ± 13

57 ± 12

64 ± 10

59 ± 10

<0.0001

BMI (≥30 kg/m2), n (%)

10 (16)

11 (20)

15 (25)

14 (22)

0.7667

Currently employed, n (%)

40 (63)

27 (49)

13 (21)

28 (44)

<0.0001

Currently employed (aged <65 years), n (%)

40 (78)

27 (64)

12 (38)

26 (59)

<0.0001

Comorbidities (≥1), n (%)

43 (67)

44 (80)

61 (100)

45 (76)

<0.0001

Dialysis in the past 12 months, n (%) a

.

.

61 (100)

5 (8)

<0.0001

 Haemodialysis

.

.

51 (84)

5 (100)

1.0000

 Peritoneal dialysis

.

.

12 (20)

0 (0)

0.5754

  1. P values calculated with χ2 test unless otherwise specified
  2. SD standard deviation, BMI body mass index
  3. aFisher’s exact test
  4. bKruskal–Wallis test